TMCnet News
Research and Markets: Specialty Drug Distribution Market Analysis 2015 - 2020 - Oncology, Multiple Sclerosis, Rheumatoid Arthritis & HemophiliaResearch and Markets (http://www.researchandmarkets.com/research/7fvvdd/specialty_drug) has announced the addition of the "Specialty Drug Distribution Market Analysis (2015 - 2020): By Drug Type (Oncology, Multiple Sclerosis, Rheumatoid Arthritis, Hemophilia); By Distribution (Retail, Home Health, Clinics, Pharmacies)" report to their offering. The Specialty Drugs Distribution Market is estimated to be $500 million in 2015. It is estimated to grow at a CAGR of 18% between 2015-2020. The driving force behind the growth is Healthcare reforms, transition in Payer dynamics and growth of Specialty Drugs. The Specialty Drug Distribution market is Oligopolistic in nature with three players dominating the market with different pricing strategies. Such a scenario creates barriers for new entrants into the market. The companies follow a pricing discount strategy which acts as a leverage for gaining market share. There are other factors such as excellent logistics, efficient supply chain and unparalleled warehousing facilities which have kept the market growing at a fast pace. The North America region is leading the market share geographically due to better healthcare reforms, increased use of Specialy Drugs to treat chronic diseases, and better distribution facilities. The European region is slowly gaining the market share in the Specialty Drug Distribution market. The vast geographical landscape in Europe serves as a major challenge in having an efficient distribution & logistics network. The highest growth is going to be witnessed in Asia Pacific region, in countries such as India, China and Australia. The reason behind the growth is improving infrastructure, and innovative distribution facilities. The Specialty Drug Distribution market is also facing challenges which restricts the market to grow steadily. The channel restriction is one of the major issues at hand. Consumers, in order to get the product at a cheaper price, try to bypass the distribution channel. This leads to counterfeiting. There is also a need to collect distribution data which will help in creating restricted access channels. Key Topics Covered: 1. Global Specialty Drug Distribution - Market Overview 2. Executive Summary 3. Global Specialty Drug Distribution - Market Landscape 4. Global Specialty Drug Distribution - Market Forces 5. Global Specialty Drug Distribution Market - Strategic Analysis 6. Global Specialty Drugs- By Application 7. Global Specialty Drug Distribution Market - By Distribution Type 8. Global Specialty Drug Distribution Market - By Distribution Channel 9. Global Specialty Drug Distribution Market - By End User 10. Global Specialty Drug Distribution Market - Geographic Analysis 11. Market Entropy 12. Company Profiles (Overview, Financials, Strategy, Developments, Product Portfolio)
For more information visit http://www.researchandmarkets.com/research/7fvvdd/specialty_drug
View source version on businesswire.com: http://www.businesswire.com/news/home/20150909005744/en/ |
